Cannabis Global (CBGL) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 14 179 sessions, September 9, 2025 to September 10, 2026
- Largest daily move
- +100% close of November 4, 2025
- 1-year change
- +0% closing prices, September 9, 2025 to September 10, 2026
- 1-month change
- +0% closing prices, August 10, 2026 to September 10, 2026
Company Description
Cannabis Global (OTC: CBGL) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $65.6K.
CBGL has gained 0.0% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for CBGL, including price data, latest news, and short interest trends.
Stock Performance
Cannabis Global (CBGL) closed at $0.0001 on September 10, 2026. Over the past 12 months, the price has gained 0.0%.
CBGL Metrics & Rankings
Price returns through September 10, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Cannabis Global has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings. View all CBGL news →
SEC Filings
Short Interest History
Short interest in Cannabis Global (CBGL) currently stands at 6.3 million shares, a new position with no short interest reported in the previous period, representing 0.5% of the float. Since November 2025, short interest has increased by 1165259.1%.
Days to Cover History
Days to cover for Cannabis Global (CBGL) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
CBGL Company Profile & Sector Positioning
Cannabis Global (CBGL) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CBGL often look at related companies in the same sector, including Pineapple Expres Cannabis (PNXP), Endexx Corp (EDXC), Hero Technologies Inc (HENC), Instadose Pharma Corp (INSD), and Petros Pharm Inc (PTPI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CBGL's relative position within its industry.